[1] |
Syngal S, Brand RE, Church JM, et al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes[J]. Am J Gastroenterol, 2015, 110(2): 223-262; quiz 263.
|
[2] |
Tomita N, Ishida H, Tanakaya K, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2020 for the clinical practice of hereditary colorectal cancer[J]. Int J Clin Oncol, 2021, 26(8): 1353-1419.
|
[3] |
Dinarvand P, Davaro EP, Doan JV, et al. Familial adenomatous polyposis syndrome: an update and review of extraintestinal manifestations[J]. Arch Pathol Lab Med, 2019, 143(11): 1382-1398.
|
[4] |
Chenbhanich J, Atsawarungruangkit A, Korpaisarn S, et al. Prevalence of thyroid diseases in familial adenomatous polyposis: a systematic review and meta-analysis[J]. Fam Cancer, 2019, 18(1): 53-62.
|
[5] |
Huang W, Bian J, Qian X, et al. Case Report: Coinheritance of germline mutations in APC and BRCA1 in colorectal cancer[J]. Front Oncol, 2021, 11: 658389.
|
[6] |
Abbott J, Nathke IS. The adenomatous polyposis coli protein 30 years on[J]. Semin Cell Dev Biol, 2023: 150-151, 28-34.
|
[7] |
Park MG, Kim JS, Park SY, et al. MicroRNA-27 promotes the differentiation of odontoblastic cell by targeting APC and activating Wnt/beta-catenin signaling[J]. Gene, 2014, 538(2): 266-272.
|
[8] |
Galiatsatos P, Foulkes WD. Familial adenomatous polyposis[J]. Am J Gastroenterol, 2006, 101(2): 385-398.
|
[9] |
Xu M, Zheng Y, Zuo Z, et al. De novo familial adenomatous polyposis associated thyroid cancer with a c.2929delG frameshift deletion mutation in APC: a case report and literature review[J]. World J Surg Oncol, 2023, 21(1): 73.
|
[10] |
Grover S, Kastrinos F, Steyerberg EW, et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas[J]. JAMA, 2012, 308(5): 485-492.
|
[11] |
Li N, Kang Q, Yang L, et al. Clinical characterization and mutation spectrum in patients with familial adenomatous polyposis in China[J]. J Gastroenterol Hepatol, 2019, 34(9): 1497-1503.
|
[12] |
Herzig D, Hardiman K, Weiser M, et al. The American society of colon and rectal surgeons clinical practice guidelines for the management of inherited polyposis syndromes[J]. Dis Colon Rectum, 2017, 60(9): 881-894.
|
[13] |
Campos FG. Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations[J]. World J Gastroenterol, 2014, 20(44): 16620-16629.
|
[14] |
de Oliveira JC, Viana DV, Zanardo C, et al. Genotype-phenotype correlation in 99 familial adenomatous polyposis patients: A prospective prevention protocol[J]. Cancer Med, 2019, 8(5): 2114-2122.
|
[15] |
Zeggini E, Gloyn AL, Barton AC, et al. Translational genomics and precision medicine: Moving from the lab to the clinic[J]. Science, 2019, 365(6460): 1409-1413.
|
[16] |
Weiss JM, Gupta S, Burke CA, et al. NCCN Guidelines(R) Insights: Genetic/familial high-risk assessment: Colorectal, Version 1.2021[J]. J Natl Compr Canc Netw, 2021, 19(10): 1122-1132.
|
[17] |
Monahan KJ, Bradshaw N, Dolwani S, et al. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG)[J]. Gut, 2020, 69(3): 411-444.
|
[18] |
Stormorken AT, Berg T, Norum OJ, et al. APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis[J]. Fam Cancer, 2018, 17(4): 539-543.
|
[19] |
Kim JC, Bodmer WF. Genotypic and Phenotypic Characteristics of Hereditary Colorectal Cancer[J]. Ann Coloproctol, 2021, 37(6): 368-381.
|
[20] |
Pavicic W, Nieminen TT, Gylling A, et al. Promoter-specific alterations of APC are a rare cause for mutation-negative familial adenomatous polyposis[J]. Genes Chromosomes Cancer, 2014, 53(10): 857-864.
|
[21] |
Wachsmannova-Matelova L, Stevurkova V, Adamcikova Z, et al. Different phenotype manifestation of familial adenomatous polyposis in families with APC mutation at codon 1309[J]. Neoplasma, 2009, 56(6): 486-489.
|
[22] |
Fukushi G, Yamada M, Kaku Gawa Y, et al. Genotype-phenotype correlation of small intestinal polyps on small-bowel capsule endoscopy in familial adenomatous polyposis[J]. Gastrointest Endosc, 2023, 97(1): 59-68.e7.
|
[23] |
Talseth-Palmer BA. The genetic basis of colonic adenomatous polyposis syndromes[J]. Hered Cancer Clin Pract, 2017, 15: 5.
|
[24] |
Leoz ML, Carballal S, Moreira L, et al. The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management[J]. Appl Clin Genet, 2015, 8: 95-107.
|
[25] |
Aelvoet AS, Buttitta F, Ricciardiello L, et al. Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights[J]. Best Pract Res Clin Gastroenterol, 2022, 58-59: 101793.
|
[26] |
Aelvoet AS, Struik D, Bastiaansen BAJ, et al. Colectomy and desmoid tumours in familial adenomatous polyposis: a systematic review and meta-analysis[J]. Fam Cancer, 2022, 21(4): 429-439.
|
[27] |
Saito Y, Hinoi T, Ueno H, et al. Risk factors for the development of desmoid tumor after colectomy in patients with familial adenomatous polyposis: multicenter retrospective cohort study in Japan[J]. Ann Surg Oncol, 2016, 23(Suppl. 4): 559-565.
|